Exact Mass: 540.3900074000001
Exact Mass Matches: 540.3900074000001
Found 255 metabolites which its exact mass value is equals to given mass value 540.3900074000001
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
TG(8:0/8:0/a-13:0)[rac]
TG(8:0/8:0/a-13:0) belongs to the family of triradyglycerols, which are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. Their general formula is [R1]OCC(CO[R2])O[R3]. TG(8:0/8:0/a-13:0) is made up of one octanoyl(R1), one octanoyl(R2), and one 10-methyldodecanoyl(R3).
TG(8:0/8:0/i-13:0)
TG(8:0/8:0/i-13:0) belongs to the family of triradyglycerols, which are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. Their general formula is [R1]OCC(CO[R2])O[R3]. TG(8:0/8:0/i-13:0) is made up of one octanoyl(R1), one octanoyl(R2), and one 11-methyldodecanoyl(R3).
TG(8:0/8:0/13:0)
TG(8:0/8:0/13:0) belongs to the family of triradyglycerols, which are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. Their general formula is [R1]OCC(CO[R2])O[R3]. TG(8:0/8:0/13:0) is made up of one octanoyl(R1), one octanoyl(R2), and one tridecanoyl(R3).
TG(a-13:0/8:0/8:0)[rac]
TG(a-13:0/8:0/8:0) belongs to the family of triradyglycerols, which are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. Their general formula is [R1]OCC(CO[R2])O[R3]. TG(a-13:0/8:0/8:0) is made up of one 10-methyldodecanoyl(R1), one octanoyl(R2), and one octanoyl(R3).
TG(i-13:0/8:0/8:0)
TG(i-13:0/8:0/8:0) belongs to the family of triradyglycerols, which are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. Their general formula is [R1]OCC(CO[R2])O[R3]. TG(i-13:0/8:0/8:0) is made up of one 11-methyldodecanoyl(R1), one octanoyl(R2), and one octanoyl(R3).
TG(13:0/8:0/8:0)
TG(13:0/8:0/8:0) belongs to the family of triradyglycerols, which are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. Their general formula is [R1]OCC(CO[R2])O[R3]. TG(13:0/8:0/8:0) is made up of one tridecanoyl(R1), one octanoyl(R2), and one octanoyl(R3).
Leptomycin B
5
5 is a member of the class of compounds known as diterpene lactones. Diterpene lactones are diterpenoids containing a lactone moiety. 5 is practically insoluble (in water) and a very weakly acidic compound (based on its pKa). 5 can be found in roman camomile, which makes 5 a potential biomarker for the consumption of this food product. 5 is a non-carcinogenic (not listed by IARC) potentially toxic compound. 5 (five ) is a number, numeral, and glyph. It is the natural number following 4 and preceding 6 . Manganese mainly affects the nervous system and may cause behavioral changes and other nervous system effects, which include movements that may become slow and clumsy. This combination of symptoms when sufficiently severe is referred to as ‚Äúmanganism‚Äù (L228) (T3DB). 5 is a member of the class of compounds known as diterpene lactones. Diterpene lactones are diterpenoids containing a lactone moiety. 5 is practically insoluble (in water) and a very weakly acidic compound (based on its pKa). 5 can be found in roman camomile, which makes 5 a potential biomarker for the consumption of this food product. 5 is a non-carcinogenic (not listed by IARC) potentially toxic compound. 5 (five ) is a number, numeral, and glyph. It is the natural number following 4 and preceding 6 . Manganese mainly affects the nervous system and may cause behavioral changes and other nervous system effects, which include movements that may become slow and clumsy. This combination of symptoms when sufficiently severe is referred to as “manganism” (L228) (T3DB).
15beta,16beta-Isopropylidenedioxy-5alpha-cholest-3beta,4beta,6alpha,7alpha,8beta,26-hexaol
22beta-isobutyryloxy-3-oxoolean-12-en-28-oic acid|lantadene D
Leptomycin B
A leptomycin having a (2E,10E,12E,16Z,18E)-double bond configuration as well as an ethyl substituent at position 17. D000890 - Anti-Infective Agents > D000935 - Antifungal Agents D000970 - Antineoplastic Agents
15??,16??-Isopropylidenedioxy-5??-cholest-3??,4??,6??,7??,8??,26-hexaol
22-Ketone,di-Ac -(3beta,22beta)-12-Oleanene-3,22,24-triol
7-oxo-8beta-D:C-friedo-olean-9(11)-ene-3alpha,29-diol diacetate
3alpha-Isobutyryloxy-2beta,15-dihydroxy-ent-labd-7-ene-2-O-beta-fucopyranoside
Ile Pro Arg Arg
Ile Arg Pro Arg
Ile Arg Arg Pro
Leu Pro Arg Arg
Leu Arg Pro Arg
Leu Arg Arg Pro
Pro Ile Arg Arg
Pro Leu Arg Arg
Pro Arg Ile Arg
Pro Arg Leu Arg
Pro Arg Arg Ile
Pro Arg Arg Leu
Arg Ile Pro Arg
Arg Ile Arg Pro
Arg Leu Pro Arg
Arg Leu Arg Pro
Arg Pro Ile Arg
Arg Pro Leu Arg
Arg Pro Arg Ile
Arg Pro Arg Leu
Arg Arg Ile Pro
Arg Arg Leu Pro
Arg Arg Pro Ile
Arg Arg Pro Leu
(5Z,7E)-(1S,3R)-25,25-diphenyl-26,27-dinor-9,10-seco-5,7,10(19)-cholestatriene-1,3,25-triol
(5b,7a,12a)-2-(3-methoxyphenyl)-2-oxoethyl ester-7,12-dihydroxy-cholan-24-oic acid
1alpha,25-dihydroxy-25,25-diphenyl-26,27-dinorvitamin D3
1,4,8,11-Tetrakis(dimethylaminocarbonylmethyl)-1,4,8,11-tetraazacyclotetradecane
(2E,24R)-24-[(alpha-L-ascarosyl)oxy]-2-methylpentacos-2-enoic acid
An (omega-1)-hydroxy fatty acid ascaroside obtained by obtained by formal condensation of the alcoholic hydroxy group of (2E,24R)-2-methylpentacos-2-enoic acid with ascarylopyranose (the alpha anomer). It is a metabolite of the nematode Caenorhabditis elegans.
O-[[[(R)-3-(Hexadecyloxy)-2-[acetylthio]propyl]oxy]phosphonyl]choline
2,3-Dihydroxypropyl (3-henicosoxy-2-hydroxypropyl) hydrogen phosphate
[3-[2,3-Dihydroxypropoxy(hydroxy)phosphoryl]oxy-2-hydroxypropyl] icosanoate
[1-[(5Z,8Z,11Z,14Z,17Z,20Z,23Z)-hexacosa-5,8,11,14,17,20,23-heptaenoxy]-3-hydroxypropan-2-yl] hexanoate
[1-hydroxy-3-[(7Z,10Z,13Z,16Z,19Z,22Z,25Z)-octacosa-7,10,13,16,19,22,25-heptaenoxy]propan-2-yl] butanoate
[1-[(4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoxy]-3-hydroxypropan-2-yl] (7Z,10Z,13Z)-hexadeca-7,10,13-trienoate
[1-[(7Z,10Z,13Z)-hexadeca-7,10,13-trienoxy]-3-hydroxypropan-2-yl] (4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoate
[1-Decoxy-3-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxypropan-2-yl] decanoate
[3-hydroxy-2-[(9E,12E)-pentadeca-9,12-dienoyl]oxypropyl] (5E,7E,9E,11E,13E)-hexadeca-5,7,9,11,13-pentaenoate
[1-carboxy-3-[3-[(9E,11E)-henicosa-9,11-dienoyl]oxy-2-hydroxypropoxy]propyl]-trimethylazanium
[3-hydroxy-2-[(6E,9E,12E)-pentadeca-6,9,12-trienoyl]oxypropyl] (7E,9E,11E,13E)-hexadeca-7,9,11,13-tetraenoate
[1-carboxy-3-[3-[(4E,7E)-deca-4,7-dienoyl]oxy-2-decanoyloxypropoxy]propyl]-trimethylazanium
C30H54NO7+ (540.3900074000001)
[1-carboxy-3-[2-[(4E,7E)-deca-4,7-dienoyl]oxy-3-decanoyloxypropoxy]propyl]-trimethylazanium
C30H54NO7+ (540.3900074000001)
[3-[2,3-bis[[(E)-dec-4-enoyl]oxy]propoxy]-1-carboxypropyl]-trimethylazanium
C30H54NO7+ (540.3900074000001)
[1-carboxy-3-[2-[(9Z,12Z)-heptadeca-9,12-dienoyl]oxy-3-propanoyloxypropoxy]propyl]-trimethylazanium
C30H54NO7+ (540.3900074000001)
[3-[3-acetyloxy-2-[(9Z,12Z)-octadeca-9,12-dienoyl]oxypropoxy]-1-carboxypropyl]-trimethylazanium
C30H54NO7+ (540.3900074000001)
[3-[3-butanoyloxy-2-[(9Z,12Z)-hexadeca-9,12-dienoyl]oxypropoxy]-1-carboxypropyl]-trimethylazanium
C30H54NO7+ (540.3900074000001)
[1-carboxy-3-[3-[(11Z,14Z)-henicosa-11,14-dienoyl]oxy-2-hydroxypropoxy]propyl]-trimethylazanium
2-[carboxy-[2-hydroxy-3-[(11Z,14Z,17Z)-icosa-11,14,17-trienoyl]oxypropoxy]methoxy]ethyl-trimethylazanium
C30H54NO7+ (540.3900074000001)
1-tuberculosinyladenosine(1+)
An organic cation that is adenosine alkylated at position N1 by a tuberculosinyl group.
methyl (6r)-6-[(1r,3ar,5ar,7r,9as,11ar)-7-(acetyloxy)-3a,6,6,9a,11a-pentamethyl-1h,2h,3h,4h,5h,5ah,7h,8h,9h,10h,11h-cyclopenta[a]phenanthren-1-yl]-2-methyl-3-methylidene-4-oxoheptanoate
(3r,6s)-6-[(1s,3r,8r,11s,12s,14s,15r,16r)-14-(acetyloxy)-7,7,12,16-tetramethyl-6-oxopentacyclo[9.7.0.0¹,³.0³,⁸.0¹²,¹⁶]octadecan-15-yl]-2-methylhept-1-en-3-yl acetate
methyl (1r,3r,4r,7s,8s,11r,12s,13s,15s,16s,18r)-13-(acetyloxy)-3,7,12-trimethyl-4-[(2r)-6-methyl-5-methylideneheptan-2-yl]-19-oxahexacyclo[13.3.1.0³,⁷.0⁸,¹⁸.0¹¹,¹⁶.0¹⁶,¹⁸]nonadecane-12-carboxylate
3-propyl-6-[(2r,3s,4e,7e,10e,12e,15r,16r,17s,18e)-3,15,17-trihydroxy-4,8,10,12,16,18-hexamethylicosa-4,7,10,12,18-pentaen-2-yl]pyran-2-one
(4r,4as,6as,6br,8ar,12ar,12br,14bs)-2,2,6a,6b,9,9,12a-heptamethyl-4-[(2-methylpropanoyl)oxy]-10-oxo-3,4,5,6,7,8,8a,11,12,12b,13,14b-dodecahydro-1h-picene-4a-carboxylic acid
methyl 3-[7-(acetyloxy)-4,8-dimethyl-5-[1-(5-methyl-6-oxo-2,3-dihydropyran-2-yl)ethyl]-12-(prop-1-en-2-yl)tetracyclo[7.5.0.0¹,¹³.0⁴,⁸]tetradecan-13-yl]propanoate
n-[14-(acetyloxy)-15-[1-(dimethylamino)ethyl]-7-(hydroxymethyl)-7,12,16-trimethyltetracyclo[9.7.0.0³,⁸.0¹²,¹⁶]octadeca-1(18),2-dien-6-yl]-2-methylbut-2-enimidic acid
[(1r,3ar,5ar,5br,7ar,8r,9s,11ar,11br,13ar,13bs)-9-(acetyloxy)-3a,5a,5b,8,11a-pentamethyl-1-(3-oxoprop-1-en-2-yl)-hexadecahydrocyclopenta[a]chrysen-8-yl]methyl acetate
6-[(1s,3r,12s,14s,16r)-14-(acetyloxy)-7,7,12,16-tetramethyl-6-oxopentacyclo[9.7.0.0¹,³.0³,⁸.0¹²,¹⁶]octadecan-15-yl]-2-methylhept-1-en-3-yl acetate
15β,16β-isopropylidenedioxy-5α-cholest-3β,4β,6α,7α,8β,26-hexaol
{"Ingredient_id": "HBIN001626","Ingredient_name": "15\u03b2,16\u03b2-isopropylidenedioxy-5\u03b1-cholest-3\u03b2,4\u03b2,6\u03b1,7\u03b1,8\u03b2,26-hexaol","Alias": "NA","Ingredient_formula": "C30H52O8","Ingredient_Smile": "CC(CCCC(C)C1C2C(C3C1(CCC4C3(C(C(C5C4(CCC(C5O)O)C)O)O)O)C)OC(O2)(C)C)CO","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "11619","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
6-{5-[5'-(6-hydroperoxy-2-hydroxy-6-methylhept-4-en-2-yl)-2'-methyl-[2,2'-bioxolan]-5-yl]-5-methyloxolan-2-yl}-2-methylhept-3-ene-2,6-diol
9'-hydroxy-6-isopropyl-5,6',10',14',16'-pentamethyl-2',20'-dioxaspiro[oxane-2,21'-tricyclo[17.3.1.0⁴,⁹]tricosane]-5',10',12',16'-tetraene-3',7'-dione
(3r,6r)-6-[(1s,3r,8r,11s,12s,14s,15r,16r)-14-(acetyloxy)-7,7,12,16-tetramethyl-6-oxopentacyclo[9.7.0.0¹,³.0³,⁸.0¹²,¹⁶]octadecan-15-yl]-2-methylhept-1-en-3-yl acetate
(1r,4r,5ar,9ar,9br,11as)-1-[(2s)-5-(3,3-dimethyloxiran-2-yl)-2-methoxyoxolan-3-yl]-3b,6,6,9a,11a-pentamethyl-7-oxo-1h,2h,4h,5h,5ah,9bh,10h,11h-cyclopenta[a]phenanthren-4-yl acetate
4-{[6-amino-2-({1,3-dihydroxy-2-[(1-hydroxydodeca-2,4-dien-1-ylidene)amino]butylidene}amino)-1-hydroxyhexylidene]amino}-3-hydroxypentanoic acid
C27H48N4O7 (540.3522817999999)
(3s,10s)-7-heptyl-5,12-dihydroxy-3,10-bis(hydroxymethyl)-14-(non-2-en-1-yl)-1,8-dioxa-4,11-diazacyclotetradeca-4,11-diene-2,9-dione
[9-(acetyloxy)-3a,5a,5b,8,11a-pentamethyl-1-(3-oxoprop-1-en-2-yl)-hexadecahydrocyclopenta[a]chrysen-8-yl]methyl acetate
(3e,6s)-6-[(2r,5s)-5-[(2r,2's,5r,5'r)-5'-[(2s,4e)-6-hydroperoxy-2-hydroxy-6-methylhept-4-en-2-yl]-2'-methyl-[2,2'-bioxolan]-5-yl]-5-methyloxolan-2-yl]-2-methylhept-3-ene-2,6-diol
(3e,6r)-6-[(2r,5s)-5-[(2r,2's,5r,5'r)-5'-[(2r,4e)-6-hydroperoxy-2-hydroxy-6-methylhept-4-en-2-yl]-2'-methyl-[2,2'-bioxolan]-5-yl]-5-methyloxolan-2-yl]-2-methylhept-3-ene-2,6-diol
(2s,3s)-2-[(1r,3ar,5ar,7s,9as,11ar)-7-(acetyloxy)-3a,6,6,9a,11a-pentamethyl-1h,2h,3h,4h,5h,5ah,7h,8h,9h,10h,11h-cyclopenta[a]phenanthren-1-yl]-6-methyl-5-methylideneheptan-3-yl acetate
7-heptyl-5,12-dihydroxy-3,10-bis(hydroxymethyl)-14-(non-2-en-1-yl)-1,8-dioxa-4,11-diazacyclotetradeca-4,11-diene-2,9-dione
(2e)-n-[(6s,7r,8r,11r,12s,14r,15s,16r)-14-(acetyloxy)-15-[(1s)-1-(dimethylamino)ethyl]-7-(hydroxymethyl)-7,12,16-trimethyltetracyclo[9.7.0.0³,⁸.0¹²,¹⁶]octadeca-1(18),2-dien-6-yl]-2-methylbut-2-enimidic acid
(1s,3br,4r,5ar,9ar,9br,11as)-1-[(2r,3s,5r)-5-[(2s)-3,3-dimethyloxiran-2-yl]-2-methoxyoxolan-3-yl]-3b,6,6,9a,11a-pentamethyl-7-oxo-1h,2h,4h,5h,5ah,9bh,10h,11h-cyclopenta[a]phenanthren-4-yl acetate
(1s,3br,4r,5ar,9ar,9br,11as)-1-[(2s,3s,5r)-5-[(2s)-3,3-dimethyloxiran-2-yl]-2-methoxyoxolan-3-yl]-3b,6,6,9a,11a-pentamethyl-7-oxo-1h,2h,4h,5h,5ah,9bh,10h,11h-cyclopenta[a]phenanthren-4-yl acetate
methyl 3-[(1s,4r,5r,7s,8s,9r,12s,13r)-7-(acetyloxy)-4,8-dimethyl-5-[(1s)-1-[(2r)-5-methyl-6-oxo-2,3-dihydropyran-2-yl]ethyl]-12-(prop-1-en-2-yl)tetracyclo[7.5.0.0¹,¹³.0⁴,⁸]tetradecan-13-yl]propanoate
methyl 6-[7-(acetyloxy)-3a,6,6,9a,11a-pentamethyl-1h,2h,3h,4h,5h,5ah,7h,8h,9h,10h,11h-cyclopenta[a]phenanthren-1-yl]-2-methyl-3-methylidene-4-oxoheptanoate
4,4',5,5'-tetramethyl-1',3-bis(3-methylbutyl)-1,3'-bis(2-phenylethyl)-[2,2'-biimidazolylidene]-1,3-diium
2,2,6a,6b,9,9,12a-heptamethyl-4-[(2-methylpropanoyl)oxy]-10-oxo-3,4,5,6,7,8,8a,11,12,12b,13,14b-dodecahydro-1h-picene-4a-carboxylic acid
6,12-bis(hydroxymethyl)-3,9-dimethyl-6,12-dinonyl-1,7-dioxacyclododecane-2,8-dione
[10-(acetyloxy)-2,4a,6a,9,9,12a,14a-heptamethyl-7-oxo-3,4,5,6,8,8a,10,11,12,13,14,14b-dodecahydro-1h-picen-2-yl]methyl acetate
methyl 3-{5-hydroxy-2,3-dimethyl-8-[5-methyl-2-(prop-1-en-2-yl)hex-4-en-1-yl]-8-(3-methylbut-2-en-1-yl)-4,7-dioxo-2,3-dihydro-1-benzopyran-6-yl}hexanoate
6-[14-(acetyloxy)-7,7,12,16-tetramethyl-6-oxopentacyclo[9.7.0.0¹,³.0³,⁸.0¹²,¹⁶]octadecan-15-yl]-2-methylhept-1-en-3-yl acetate
(2e,10e,12e,16z,18e)-17-ethyl-6-hydroxy-3,5,7,9,11,15-hexamethyl-19-(3-methyl-6-oxo-2,3-dihydropyran-2-yl)-8-oxononadeca-2,10,12,16,18-pentaenoic acid
(7e,15e,19e)-4,6,12,18-tetrahydroxy-21-methyl-10-methylidene-22-[(1e,3z,5z)-3-methylnona-1,3,5,8-tetraen-1-yl]-1-oxacyclodocosa-7,15,19-trien-2-one
5-(5-hydroxy-3-methylpentyl)-1,1,4a,6-tetramethyl-3-[(3,4,5-trihydroxy-6-methyloxan-2-yl)oxy]-2,3,4,5,8,8a-hexahydronaphthalen-2-yl 2-methylpropanoate
(4s)-4-{[(2s)-6-amino-2-{[(2s,3r)-1,3-dihydroxy-2-{[(2e,4e)-1-hydroxydodeca-2,4-dien-1-ylidene]amino}butylidene]amino}-1-hydroxyhexylidene]amino}-3-hydroxypentanoic acid
C27H48N4O7 (540.3522817999999)